Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial.
Journal: JCO precision oncology
Published: August 21, 2026
Characteristics of Retracted Publications in the Ophthalmology Literature.
Journal: JAMA ophthalmology
Published: April 09, 2026
Discordant molecular biomarkers in unfavorable intermediate-risk localized prostate cancer.
Journal: CA: a cancer journal for clinicians
Published: March 31, 2026
The Association of p27 With Prostate Cancer Outcomes: A Secondary Analysis of NRG/RTOG 8610 and 9202.
Journal: Advances in radiation oncology
Published: January 12, 2026
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 23, 2025
Salvage Stereotactic Body Radiation Therapy for Locally Recurrent Prostate Cancer: Quality-of-Life Outcomes From a Prospective Clinical Trial.
Journal: Practical radiation oncology
Published: July 23, 2025
Optimizing Radiation Therapy for Localized Prostate Cancer: Exploring Synergies With Androgen Deprivation Therapy and Novel Systemic Agents.
Journal: Seminars in radiation oncology
Published: February 11, 2025
Locoregional Therapies for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Journal: JAMA network open
Published: November 27, 2024
The Benefit of Short-Term Androgen Deprivation Therapy with Radiation Therapy for Intermediate-Risk Prostate Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: November 19, 2024
Maximum Surgical Resection Followed by Radiation Therapy for the Management of Mucinous Adenocarcinoma of the Prostate.
Journal: International journal of radiation oncology, biology, physics
Published: October 21, 2024
Evaluating deep learning and radiologist performance in volumetric prostate cancer analysis with biparametric MRI and histopathologically mapped slides.
Journal: Abdominal radiology (New York)
Published: September 07, 2024
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials.
Journal: European urology oncology
Published: September 06, 2024
Last Updated: 09/26/2026